Curcumin in heart failure: A choice for complementary therapy?-Reference-Cited by-同舟云学术

Curcumin in heart failure: A choice for complementary therapy?

Published:2018-05 Issue: Volume:131 Page:112-119
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Saeidinia Amin,Keihanian Faeze,Butler Alexandra E.,Bagheri Ramin Khameneh,Atkin Stephen L.,Sahebkar Amirhossein

Publisher

Elsevier BV

Subject

Pharmacology

Reference121 articles.

1. Epidemiology of heart failure;Roger;Circ. Res.,2013

2. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America;Yancy;J. Am. Coll. Cardiol.,2017

3. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012;McMurray;Eur. J. Heart Fail.,2012

4. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure;Li;J. Am. Coll. Cardiol.,2013

5. The future of pharmacological therapy for heart failure;Sata;Circ. J.,2010

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Cardiovascular Diseases by Short-Chain Fatty Acid Postbiotics;Current Nutrition Reports;2024-04-24

2. Curcumin simultaneously improves mitochondrial dynamics and myocardial cell bioenergy after sepsis via the SIRT1-DRP1/PGC-1α pathway;Heliyon;2024-04

3. The recent advance and prospect of natural source compounds for the treatment of heart failure;Heliyon;2024-03

4. Esterase-triggered rapid release of succinic anhydride conjugated curcumin co-prodrug for osteosarcoma therapy;European Polymer Journal;2023-10

5. Mitochondrial dysfunction and type I interferon signaling induce anxiodepressive-like behaviors in mice with neuropathic pain;Experimental Neurology;2023-09